At the University of Utah School of Medicine Center for Iron and Hematology Disorders (CIHD), we like to say “We put the Heme in Hematology”. Our center supports four cores: 1) the Iron & Heme Core that focuses on measuring the activity of enzymes that synthesize heme and heme precursor molecules as well as determining transition metal levels in biologic samples; 2) the Protein Metabolite Interaction Core utilizes a unique system to find metabolites that bind to your protein of interest. Identifying how these small molecules activate, stabilize or repress your protein are then assessed; 3) our Metabolomics/Lipidomics Core specializes in identifying metabolic changes in the basic building blocks of cells, molecules necessary in the bioenergetics of cells and lipids that are both functional and structural and 4) we have a robust Enrichment Program focused on training researchers with a focus on iron and heme metabolism, hematopoiesis and erythroid biology.
Welcome
U54 Center for Iron & Hematology Disorders at The University of Utah School of Medicine
Meet the Utah CCEH (CIHD) Team
-
Anna Beaudin, PhD
-
Hector Bergonia
-
Megan Bowler
-
James Cox, PhD
-
Terra Curley
-
Crystal Davey, PhD
-
Elliot Francis
-
Kevin Hicks, PhD
-
Kristin Larrabee
-
Diane Ward, PhD
-
Iryna Wiley
CIHD YouTube Channel
Want to learn more about Fe-S clusters, heme synthesis and iron homeostasis?
Listen to Dr. Tracey Rouault’s talk sponsored by the Utah CCEH.
Check out other videos on our YouTube Channel
-
Shannon Buckley, PhDHuntsman Cancer InstituteUniversity of Utahhttps://buckleylab.org/The goal of my lab is to utilize genomic and proteomic approaches in hematopoietic stem cells as well as mouse models to study molecular mechanisms regulating cell fate decisions. Our research specially focuses on studying post-transcriptional regulation by ubiquitin E3 ligases in stem cell self-renewal, maintenance, and differentiation. Our work has demonstrated a key role of UBR5 in hematopoietic stem cell development and maintenance Interestingly, over expression of Ubr5 during hematopoietic development leads to bone marrow failure, loss of hematopoietic stem and progenitor cells, and anemia by 6 weeks of age in homozygous UBR5 mutant mice suggesting a novel model to study bone marrow failure. We also study the FBOX family of ubiquitin E3 ligases, which contains ~69 E3 ligases. To date only 15 of the 69 FBOX proteins have a known role in normal hematopoiesis. We are currently studying a number of FBOX proteins to understand their role in hematopoietic stem cell maintenance, and differentiation. Our aim is to understand basic mechanisms underlying hematopoietic specification.
-
Jennifer DuBois, PhDChemistry & BiochemistryMontana State Universityhttps://chemistry.montana.edu/directory/1583497/jennifer-dubois
-
Shannon Elf, PhDUniversity of Utahhttps://www.elflab.org/
The primary focus of my lab is to understand the molecular mechanisms that govern myeloid blood cancers, with particular emphasis on myeloproliferative neoplasms (MPNs). The long-term vision for my research program is to elucidate molecular dependencies specific to MPN stem cells (MPN-SCs) that can be targeted for therapeutic intervention with the ultimate goal of eradicating MPN-SCs, sparing normal HSCs, and curing the disease. The focus of my research program during the first five years of my independent career was to identify differential molecular dependencies in type 1 versus type 2 calreticulin (CALR) mutated MPNs. As a postdoctoral fellow, I identified the shared gain-of-function mechanism by which both type 1 and type 2 mutant CALR proteins transform cells to drive disease. This work served as a foundation to subsequently understand how these two mutation types differ in their disease driving mechanisms. To this end, we identified the unfolded protein response (UPR) as differentially exploited by type 1 and type 2 CALR mutant cells, and that the UPR arm preferentially activated by each mutation type is dependent on specific losses-of-function (LOFs) engendered by type 1 versus type 2 CALR mutations. We found that type 1 CALR mutations cause loss of calcium (Ca2+) binding function, leading to depletion of ER Ca2+ and activation of and dependency on the IRE1/XBP1 pathway of the UPR, while type 2 CALR mutations cause loss of chaperone function leading to activation of and dependency on the ATF6 pathway of the UPR. These discoveries led us to investigate how these LOFs affect other cellular processes, and found that loss of Ca2+ binding by type 1 CALR mutations leads to metabolic reprogramming and a dependency on glycolytic metabolism via increased cytosolic and mitochondrial Ca2+, while loss of chaperone function leads to impaired MHC-I processing and dysregulation of natural killer cell-based immune surveillance of type 2 CALR mutant cells. We are currently seeking to understand how these observations affect MPN-SCs and other disease-driving cells in primary human cell and mouse models, and whether these pathways represent novel therapeutic targets that can eradicate MPN-SCs to cure the disease.
-
Dengke Ma, PhDSchool of MedicineUniversity of California – San Franciscohttps://malab.ucsf.edu/
Natural and synthetic physiology of life’s resilience
We are fascinated by the natural and synthetic physiology of life’s resilience. Many organisms in nature have evolved specialized traits to respond and adapt to severe environmental stresses, including hypothermia (cold) or hypoxia (low oxygen). For example, Arctic ground squirrels can tolerate extremely low levels of oxygen in the brain and heart during hibernation. Most nematodes, including those from Antarctica and the common model organism C. elegans, can enter “suspended animation” states upon anoxia; they can also be frozen alive and suspend life that can be revived later virtually any long after freezing, unlike many other multicellular organisms. We use cultured neural stem cells from hibernating Arctic ground squirrels and nematodes with extremophile-like phenotypes recapitulated in the laboratory as discovery tools to discover novel cellular and physiological resilience mechanisms. Genes identified from such systems via large-scale experimental screens or computational mining often encode proteins of unusual properties that define novel mechanisms underlying cytoprotection, cellular organelle dynamics, and organismal homeostasis in physiology and behaviors. Some were even acquired from extremophile microbes via horizontal gene transfers and functionally co-opted to confer stress resilience. We take advantage of findings from our research and aim to use synthetic physiology approaches to engineer biological systems that may foster new means of neuroprotection, organ transplantation, reversible cryo-preservation, and therapeutics to treat ischemic, neurological, and age-related disorders.
Current lab members:Andrew Wong (URAP student)
Bingying Wang (Lab manager)
Dengke Ma (Principal Investigator)
Fiona Oh (URAP student)
Jason DeGeorge (URAP student)
Jenny Zu (URAP student)
Minseo Kim (URAP student)
Taruna Pandey (Postdoc)
Wei Jiang (Postdoc)
Winfred Zhijian Ji (Postdoc)